316
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Weekly subcutaneous injection of tocilizumab in patients with rheumatoid arthritis

Pages 17-19 | Received 31 Jul 2017, Accepted 15 Sep 2017, Published online: 18 Oct 2017
 

Conflict of interest

S. Ito has received a speaking fee (approximately US $5000) from Abbott Japan Co., Ltd.; Bristol-Myers Squibb; Eisai Co., Ltd.; Mitsubishi Tanabe Pharma Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; and Janssen Pharmaceutical K.K.

Log in via your institution

Log in to Taylor & Francis Online

There are no offers available at the current time.

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.